- Adherence
- Children
- Clinical reviews
- Drug supply
- Guidelines
- Hepatitis and HIV coinfection
- HIV Testing
- Infant feeding
- Laboratory monitoring
- Malaria & HIV
- Neurological problems, including HIV dementia
- Nutrition
- Palliative care
- Prevention
- Prevention of mother-to child transmission
- Scaling up treatment and models of service delivery
- Side-effects
- South Africa
- Palliative care: pain and symptom control being ignored in South Africa due to lack of training, legal barriers - 10/9/2007
- How to deliver good adherence support: lessons from round the world - 10/9/2007
- A follow-up on follow-up: shifting to a community-based response to improve retention in care - 31/8/2007
- HIV treatment and displaced populations - 27/6/2007
- Scaling up laboratory capacity for the coming storm of XDR-TB, and why the HIV treating community must get involved now - 28/11/2006
- South African Treatment Scale-up Progress Report - 27/10/2005
- South Africa - Is slow progress a sign of lack of commitment? - 27/10/2005
- Starting treatment
- Stigma
- Treatment failure
- Tuberculosis
- Viral load testing
South Africa
Palliative care: pain and symptom control being ignored in South Africa due to lack of training, legal barriers - 10/9/2007
How to deliver good adherence support: lessons from round the world - 10/9/2007
A follow-up on follow-up: shifting to a community-based response to improve retention in care - 31/8/2007
HIV treatment and displaced populations - 27/6/2007
Scaling up laboratory capacity for the coming storm of XDR-TB, and why the HIV treating community must get involved now - 28/11/2006
South African Treatment Scale-up Progress Report - 27/10/2005
South Africa - Is slow progress a sign of lack of commitment? - 27/10/2005
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.
latest aidsmap news
- Brazil rejects tenofovir patent
- Fibrosis linked to rapid loss of gut CD4 cells after HIV infection
- Poor results using non-medical HIV counsellors to screen for treatment eligibility in Malawi
- Raltegravir may cause temporary worsening of pre-existing depression
- Etravirine (<i>Intelence</i>) approved in Europe for treatment-experienced patients
- Belief in conspiracy theories means less HIV testing in South Africa
- Case report - viral load undetectable in blood, but detectable in semen
- 'Hidden epidemic' of HIV amongst African migrants in the United States
- Blood viral load predicts HIV transmission better than semen viral load in small study among MSM
- Infectiousness and antiretroviral therapy: reports look set to further fuel the debate